Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito AM, Fujimoto J, Horibe K, Nagao M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Tomizawa D, Taga T, Tawa A, Tanaka S, Heike T, Adachi S.
Tokumasu M, et al. Among authors: shimada a.
Leukemia. 2015 Dec;29(12):2438-41. doi: 10.1038/leu.2015.121. Epub 2015 May 15.
Leukemia. 2015.
PMID: 25975190
No abstract available.